As of Friday close, Agenus Inc.’s (NASDAQ:AGEN) stock was up $0.01, moving up 0.69 percent to $1.46. The average number of shares traded per day over the past five days has been 3,236,700 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.0700 fall in that time frame. In the last twenty days, the average volume was 3,132,970, while in the previous 50 days, it was 5,176,504.
Since last month, AGEN stock retreated -7.01%. Shares of the company fell to $1.4200 on 08/02/23, the lowest level in the past month. A 52-week high of $3.31 was reached on 01/13/23 after having rallying from a 52-week low of $1.28. Since the beginning of this year, AGEN’s stock price has dropped by -38.01% or -$0.9400, and marked a new high 6 times. However, the stock has declined by -55.85% since its 52-week high.
AGEN stock investors should be aware that Agenus Inc. (AGEN) stock had its last reported insider trading activity 86 days ago on May 11. AGENUS INC, the 10% Owner of the company, purchased of 23,361 shares for $1.43 on May 11. It resulted in a $33,348 investment by the insider. AGENUS INC added 22,065 shares at an average price of $1.51 on May 10. The insider now owns 21,617,112 shares following the transaction. On May 05, 10% Owner AGENUS INC bought 100,200 shares at $0.95 apiece. The transaction was valued at $95,100.
Financial Health
In the three months ended March 30, Agenus Inc.’s quick ratio stood at 1.10, while its current ratio was 1.10, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 87.00% percent. Based on annual data, AGEN earned $87.46 million in gross profit and brought in $98.02 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 650.10%. Return on equity (ROE) for the past 12 months was 702.50%.
In Agenus Inc.’s quarter-end financial report for March 30, it reported total debt of $12.63 million against cash and short-term investments of $24.41 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. AGEN’s revenue fell -13.28% to $28.39 million during the quarter, while net income inched up to $22.9 million. While analysts expected Agenus Inc. to report -$0.21 quarterly earnings, the actual figure was -$0.22 per share, beating the consensus estimate by -4.80%. During the quarter, the company generated -$51.78 million in EBITDA. The liabilities of Agenus Inc. were 465.96 million at the end of its most recent quarter ended March 30, and its total debt was $101.66 million. The value of shareholders’ equity is $348.88 million.
Technical Picture
This quick technical analysis looks at Agenus Inc.’s (AGEN) price momentum. With a historical volatility rate of 41.94%, the RSI 9-day stood at 34.06% on 04 August.
With respect to its five-day moving average, the current Agenus Inc. price is down by -4.58% percent or -$0.0700. At present, AGEN shares trade -10.98% below its 20-day simple moving average and -14.62% percent below its 100-day simple moving average. However, the stock is currently trading approximately -3.95% below its SMA50 and -45.52% below its SMA200.
Stochastic coefficient K was 8.77% and Stochastic coefficient D was 7.98%, while ATR was 0.0764. Given the Stochastic reading of 12.50% for the 14-day period, the RSI (14) reading has been calculated as 38.29%. As of today, the MACD Oscillator reading stands at -0.0278, while the 14-day reading stands at -0.0867.
Analyst Ratings
Robert W. Baird launched its rating on Agenus Inc. (NASDAQ: AGEN) to an Outperform in a note to investors on June 06, 2023. Agenus Inc. (AGEN) has been rated Buy by analysts. According to 0 brokerage firms, AGEN is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Agenus Inc. stock as buy, with 5 recommending it as overweight.
With a median target price of $8.00, the current consensus forecast for the stock is $6.00 – $8.30. Based on these forecasts, analysts predict Agenus Inc. (AGEN) will achieve an average price target of $7.66.
